Absolute Gestao de Investimentos’s Apellis Pharmaceuticals APLS Stock Holding History

Absolute Gestao de Investimentos’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.1M	Buy	+450,000	New	+$9.7M	2.06%	13

Other funds holding APLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Absolute Gestao de Investimentos's APLS Position: Q1 2026 in Review

Absolute Gestao de Investimentos opened a new position in Apellis Pharmaceuticals (APLS) in Q1 2026: 450,000 shares worth $18.1M. The stake represents 2.06% of the portfolio and ranks #13 among its holdings.

323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

Absolute Gestao de Investimentos held 450,000 shares of Apellis Pharmaceuticals worth $18.1M as of Q1 2026.
Apellis Pharmaceuticals was a new Absolute Gestao de Investimentos position in Q1 2026.
Apellis Pharmaceuticals made up 2.06% of Absolute Gestao de Investimentos's portfolio in Q1 2026, its #13 holding.
323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Absolute Gestao de Investimentos's 13F filing for Q1 2026, filed 15 May 2026.